Archive
Home / Media Centre / Archive
Here you can find the archive of all Press Releases prior to 2022
Filter by date:
Showing 1107 press releases before 2022
-
AstraZeneca presents positive pooled analysis demonstrating the effect of dapagliflozin on albuminuria in hypertensive patients with type 2 diabetes
-
AstraZeneca announces new tolerability, long-term efficacy and real-world adherence data for exenatide once weekly in patients with type 2 diabetes
-
AstraZeneca to present comprehensive data from its diabetes portfolio and pre-clinical research at EASD 2015
-
AstraZeneca purchases US biologics manufacturing facility to support growing pipeline
-
AstraZeneca to invest £11.5 million in new clinical oncology bioinformatics collaboration with The University of Manchester
-
AstraZeneca to update on leading lung cancer portfolio at WCLC 2015
-
US FDA approves expanded indication for BRILINTA to include long-term use in patients with a history of heart attack
-
AstraZeneca enters license agreement with Daiichi Sankyo for development and commercialisation of FluMist in Japan
-
Positive Phase III results demonstrate efficacy of antibiotic medicine CAZ-AVI in complicated Urinary Tract Infections
-
AstraZeneca and Valeant Pharmaceuticals to partner on brodalumab
Latest articles and press releases
All of our latest press releases and articles are available to explore
